NCT06616571
- Conditions
- Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Shandong Cancer Hospital Jinan, Shandong, China
Clinical trial condition
Chemotherapy-Induced Febrile Neutropenia
Explore clinical trials studying Chemotherapy-Induced Febrile Neutropenia. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Chemotherapy-Induced Febrile Neutropenia trial results
NCT02467868
- Conditions
- Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Mylan Investigational Site 3502 Plovdiv, Bulgaria
- Mylan Investigational Site 3506 Plovdiv, Bulgaria
- Mylan Investigational Site 3507 Plovdiv, Bulgaria
- Mylan Investigational Site 3503 Sofia, Bulgaria
NCT04000711
- Conditions
- Agranulocytosis, Body Temperature Changes, Chemotherapy-Induced Febrile Neutropenia, +11 more
- Locations
-
Not specified
NCT02178475
- Conditions
- Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Research Site Eggenburg, Austria
- Research Site Graz, Austria
- Research Site Leoben, Austria
- Research Site Schwarzach im Pongau, Austria
NCT01813721
- Conditions
- Agranulocytosis, Breast Diseases, Breast Neoplasms, +17 more
- Locations
-
- Research Site Tweed Heads, New South Wales, Australia
- Research Site Bendigo, Victoria, Australia
- Research Site Shepparton, Victoria, Australia
- Research Site Wodonga, Victoria, Australia